Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Pump vs MDI in Malaysian T2DM
NCT03112538Phase 4Unknown
- Sponsor
- Clinical Research Malaysia
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Clinical Research Malaysia. Primary endpoint: Change in Glycated Hemoglobin (HbA1c) at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03112538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112538.